Disease Burden of Invasive Meningococcal Disease in the Netherlands between 2011 and 2019

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON26020

Enrollment

330

Registered

2020-03-05

Start date

2020-05-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Invasive Meningococcal Disease.

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients with IMD hospitalized in a Dutch hospital between 2011 and 2019 will be included.

Exclusion criteria

Exclusion criteria: Not hospitalized with IMD.

Design outcomes

Primary

Measure	Time frame
The main objective of this study is to provide updated and representative information on the burden of IMD in the Netherlands between July 2011 and May 2020.	—

Secondary

Measure	Time frame
we have established the following secondary objectives: 1. Describe the case characteristics of hospitalized patients with IMD in the Netherlands between July 2011 and May 2020. 2. Identify the clinical manifestation of IMD (e.g. meningitis and septic shock) in the Netherlands between July 2011 and May 2020. 3. Gain insight in the disease course (in specific the time between diagnosis and hospital admission) of hospitalized patients with IMD in the Netherlands between July 2011 and May 2020. 4. Identify the disease outcome(e.g. case-fatality and sequelae) of hospitalized patients with IMD in the Netherlands between July 2011 and October 2019	—

Measure

Time frame

we have established the following secondary objectives: 1. Describe the case characteristics of hospitalized patients with IMD in the Netherlands between July 2011 and May 2020. 2. Identify the clinical manifestation of IMD (e.g. meningitis and septic shock) in the Netherlands between July 2011 and May 2020. 3. Gain insight in the disease course (in specific the time between diagnosis and hospital admission) of hospitalized patients with IMD in the Netherlands between July 2011 and May 2020. 4. Identify the disease outcome(e.g. case-fatality and sequelae) of hospitalized patients with IMD in the Netherlands between July 2011 and October 2019

—

Contacts

Public ContactMarit Middeldorp

RIVM

marit.middeldorp@rivm.nl+31 030 274 2066

Outcome results